公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2023 | Gamma-glutamyl transferase levels in the prediction of the outcomes of hepatocellular carcinoma after surgical resection | TUNG-HUNG SU ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 0 | 0 | |
1999 | GB virus C infection in hemodialysis patients: Molecular evidence for nosocomial transmission | JIA-HORNG KAO ; Huang C.-H.; Chen W.; TUN-JUN TSAI ; Lee S.-H.; KUAN-YU HUNG ; DING-SHINN CHEN | Journal of Infectious Diseases | 18 | 13 | |
1998 | GB virus C/hepatitis G virus infection in patients on continuous ambulatory peritoneal dialysis | Huang C.-H.; JIA-HORNG KAO ; Kuo Y.-M.; TUN-JUN TSAI ; KUAN-YU HUNG ; DING-SHINN CHEN | Nephrology Dialysis Transplantation | 7 | 8 | |
1997 | GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; Chen W.; DING-PING LIU ; JANN-TAY WANG ; Shen M.- C.; DING-SHINN CHEN | Gastroenterology | 82 | 73 | |
1997 | GB virus-C/hepatitis G virus infection in prostitutes: Possible role of sexual transmission | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.Y.; Lin R.Y.; DING-SHINN CHEN | Journal of Medical Virology | 35 | ||
1999 | GB virus-C/hepatitis G virus infection in Taiwan: A virus that fails to cause a disease? | JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Biomedical Science | 15 | 0 | |
1996 | GBV-C in the aetiology of fulminant hepatitis [6] | JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Mishiro S.; Yoshiba M.; Okamoto H. | Lancet | 83 | 87 | |
1996 | GBV-C/HGV infection and aplastic anaemia [7] | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Lancet | 9 | 8 | |
2020 | Gender difference in the association between metabolic factors and hepatocellular carcinoma | CHI-LING CHEN ; Kuo M.-J.; Ming-Fang Yen A.; WEI-SHIUNG YANG ; JIA-HORNG KAO ; PEI-JER CHEN ; Chen, Tony Hsiu Hsi | JNCI Cancer Spectrum | 15 | 13 | |
2018 | Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study | CHEN-HUA LIU ; Huang Y.-J; Yang S.-S; Chang C.-H; Yang S.-S; HSIN-YUN SUN ; CHUN-JEN LIU ; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Scientific Reports | 25 | 23 | |
2018 | Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection | CHEN-HUA LIU ; HSIN-YUN SUN ; CHUN-JEN LIU ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; Lo Y.-C; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 24 | 21 | |
2002 | Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study | King J.K.; Shiou-Hwei Yeh ; Lin M.-W.; CHUN-JEN LIU ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Hepatology | 63 | 54 | |
2008 | Genetic variability of hepatitis B virus and response to antiviral therapy | CHUN-JEN LIU ; JIA-HORNG KAO | Antiviral Therapy | 40 | 28 | |
2019 | Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B | Wei L.; Pavlovic V.; Bansal A.T.; Chen X.; Foster G.R.; He H.; JIA-HORNG KAO ; Lampertico P.; Liaw Y.-F.; Motoc A.; Papatheodoridis G.V.; Piratvisuth T.; Plesniak R.; Wat C. | Journal of Viral Hepatitis | 2 | 2 | |
2012 | Genomic variation-guided management in chronic hepatitis C | Hsu C.-S.; JIA-HORNG KAO | Expert Review of Gastroenterology and Hepatology | 9 | 9 | |
2002 | Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Clinical Microbiology | 176 | 156 | |
1995 | Genotypes of hepatitis C virus in taiwan and the progression of liver disease | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; PEI-MING YANG ; JIN-CHUAN SHEU ; Wang T.-H.; DING-SHINN CHEN | Journal of Clinical Gastroenterology | 62 | 56 | |
2004 | Genotypic Dominance and Novel Recombinations in HBV Genotype B and C Co-Infected Intravenous Drug Users | Chen B.-F.; JIA-HORNG KAO ; CHUN-JEN LIU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Medical Virology | 44 | 38 | |
2020 | Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment | CHEN-HUA LIU ; Yang S.-S.; Peng C.-Y.; Lin W.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 20 | 20 | |
2020 | Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; CHIEN-CHING HUNG ; SZU-MIN HSIEH ; TUNG-HUNG SU ; HSIN-YUN SUN ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | 21 | 20 |